The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
What are the limiting factors related to discontinuance of chemotherapy after failure of first-line S-1 plus CDDP in Japanese patients with advanced gastric cancer?
Yoshihito Ohhara
No relevant relationships to disclose
Keisho Chin
No relevant relationships to disclose
Mariko Ogura
No relevant relationships to disclose
Mitsukuni Suenaga
No relevant relationships to disclose
Eiji Shinozaki
No relevant relationships to disclose
Satoshi Matsusaka
No relevant relationships to disclose
Nobuyuki Mizunuma
No relevant relationships to disclose
Toshiharu Yamaguchi
No relevant relationships to disclose
Kiyohiko Hatake
No relevant relationships to disclose